Trial intelligence / Profile preview

SAVE trial

2025-523709-13-00Phase 3Authorised

Sponsor
Hospital de la Santa Creu i Sant Pau Research Institute
Start
Apr 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in ischemic stroke comparing Sevoflurane anesthesia arm with Propofol anesthesia arm (2 arms). Primary endpoint: Final infarct volume at 72 hours. Planned start Apr 2026; status: authorised.

02

Drugs

sevofluranepropofol
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on 2025-523709-13-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2025-523709-13-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call